BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 38434702)

  • 1. Nomogram built based on machine learning to predict recurrence in early-stage hepatocellular carcinoma patients treated with ablation.
    Zhang H; Sheng S; Qiao W; Sun Y; Jin R
    Front Oncol; 2024; 14():1395329. PubMed ID: 38800405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Low HBV-DNA Viral Load on Recurrence in Hepatocellular Carcinoma Patients Who Underwent Primary Locoregional Treatment and the Development of a Nomogram Prediction Model.
    Xiong Y; Wang Z; Liu J; Li K; Zhang Y
    Microorganisms; 2024 May; 12(5):. PubMed ID: 38792805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Nomogram to Predict Prognosis of Advanced Hepatocellular Carcinoma Treated with Intensity-Modulated Radiotherapy Plus Anti-PD1.
    He M; Liang C; Pang Y; Jiang M; Long M; Yao Z; Wang X; Zhang R; Wu Q; Liang S; Li J
    J Hepatocell Carcinoma; 2024; 11():913-925. PubMed ID: 38799002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and evaluation of a prognostic model for patients with unresectable gastric cancer liver metastases.
    Chang ZY; Gao WX; Zhang Y; Zhao W; Wu D; Chen L
    World J Clin Cases; 2024 May; 12(13):2182-2193. PubMed ID: 38808342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hepatocellular carcinoma risk in patients with HBV-related cirrhosis: a competing risk nomogram based on a 4-year retrospective cohort study.
    Guo D; Li J; Zhao P; Mei T; Li K; Zhang Y
    Front Oncol; 2024; 14():1398968. PubMed ID: 38817899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Nomogram to Predict Prognosis in Elderly Early-Stage Hepatocellular Carcinoma Patients After Ablation Therapy.
    Tang X; Wang Q; Jin R; Hu C
    J Hepatocell Carcinoma; 2024; 11():901-911. PubMed ID: 38774590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a mortality risk prediction model for patients with acute diquat poisoning based on clinically accessible data.
    Lv M; Du Y
    J Occup Med Toxicol; 2024 May; 19(1):20. PubMed ID: 38773656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing and validating a nomogram for early predicting the need for intestinal resection in pediatric intussusception.
    Yu YY; Zhang JJ; Xu YT; Lin ZX; Guo SK; Li ZR; Huang HY; Huang XZ
    Front Pediatr; 2024; 12():1409046. PubMed ID: 38774298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival analysis of the surgical treatment of hepatocellular carcinoma at a tertiary care center.
    Magadan Álvarez C; Olmos-Martínez JM; González Tolaretxipi E; Lozano Najera A; Toledo Martínez E; Rodríguez Sanjuan JC
    Rev Gastroenterol Mex (Engl Ed); 2024 May; ():. PubMed ID: 38789311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing Neonate-specific Prognostic Markers in Acute Liver Failure: Admission Alpha Fetoprotein and Novel Neonatal Acute Liver Failure Scores Predict Patient Outcomes.
    Rolfes PS; Sundaram SS; Sokol RJ; Taylor SA
    J Pediatr; 2024 Apr; 272():114080. PubMed ID: 38692563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a nomogram based on perioperative risk factors for the prediction of early thrombotic complications following pediatric liver transplantation.
    You Q; Qu E; Zeng K; Liu J; Yang Q; Tang H; Feng X; Yao J; Huang X; Zhang T; Fu B; Li H; Zhao H; Zheng J; Yi S; Yang Y
    Chin Med J (Engl); 2024 May; ():. PubMed ID: 38816681
    [No Abstract]   [Full Text] [Related]  

  • 12. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma.
    Zhang SW; Zhang NN; Zhu WW; Liu T; Lv JY; Jiang WT; Zhang YM; Song TQ; Zhang L; Xie Y; Zhou YH; Lu W
    Front Oncol; 2022; 12():946531. PubMed ID: 35936698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a nomogram to predict the recurrence of hepatocellular carcinoma patients with dynamic changes in AFP undergoing locoregional treatments.
    Sun Y; Xiong Y; Wang Q; Qiao W; Zhang H; Zhang Y
    Front Oncol; 2023; 13():1206345. PubMed ID: 37700838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel nomogram to predict the overall survival of early-stage hepatocellular carcinoma patients following ablation therapy.
    Zhang H; Sheng S; Qiao W; Han M; Jin R
    Front Oncol; 2024; 14():1340286. PubMed ID: 38384805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nomogram prognostic model for early hepatocellular carcinoma with diabetes mellitus after primary liver resection based on the admission characteristics.
    Zhang M; Wang Q; Zhang G; Li G; Jin R; Xing H
    Front Pharmacol; 2024; 15():1360478. PubMed ID: 38434702
    [No Abstract]   [Full Text] [Related]  

  • 17. Construction and validation of a machine learning-based nomogram to predict the prognosis of HBV associated hepatocellular carcinoma patients with high levels of hepatitis B surface antigen in primary local treatment: a multicenter study.
    Xiong Y; Qiao W; Wang Q; Li K; Jin R; Zhang Y
    Front Immunol; 2024; 15():1357496. PubMed ID: 38601167
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.